Xtant Medical Holdings (XTNT) Cash from Investing Activities (2010 - 2025)
Xtant Medical Holdings (XTNT) reported Cash from Investing Activities of $4.7 million for Q3 2025, up 332.9% year-over-year from $1.1 million in Q3 2024, and up 1576.03% quarter-over-quarter from -$317000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Cash from Investing Activities (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Cash from Investing Activities data on file, last reported at $4.7 million in Q3 2025.
- Cash from Investing Activities for Q3 2025 came in at $4.7 million, up 332.9% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.7 million (up 148.43% YoY), and the FY2024 annual result was -$3.7 million, up 84.95% from the prior year.
- Cash from Investing Activities climbed to $4.7 million in Q3 2025 per XTNT's latest filing, from -$317000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $4.7 million in Q3 2025 and troughed at -$17.4 million in Q1 2023.
- A 5-year average of -$1.5 million and a median of -$483000.0 in 2021 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities slumped 4355.5% in 2023, then surged 332.9% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$595000.0 in 2021, then rose by 29.08% to -$422000.0 in 2022, then slumped by 448.1% to -$2.3 million in 2023, then jumped by 75.49% to -$567000.0 in 2024, then jumped by 925.22% to $4.7 million in 2025.
- Business Quant data shows XTNT's Cash from Investing Activities at $4.7 million in Q3 2025, -$317000.0 in Q2 2025, and -$1.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Xtant Medical Holdings | 62.75 Mn | 45.42 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.68 Mn |
| Sep 30, 2025 | 4.68 Mn |
| Jun 30, 2025 | -317,000.00 |
| Jun 30, 2025 | -317,000.00 |
| Mar 31, 2025 | -1.14 Mn |
| Mar 31, 2025 | -1.14 Mn |
| Dec 31, 2024 | -567,000.00 |
| Dec 31, 2024 | -567,000.00 |
| Sep 30, 2024 | -2.01 Mn |
| Sep 30, 2024 | -2.01 Mn |
| Jun 30, 2024 | -480,000.00 |
| Jun 30, 2024 | -480,000.00 |
| Mar 31, 2024 | -674,000.00 |
| Mar 31, 2024 | -674,000.00 |
| Dec 31, 2023 | -2.31 Mn |
| Dec 31, 2023 | -2.31 Mn |
| Sep 30, 2023 | -4.66 Mn |
| Sep 30, 2023 | -4.66 Mn |
| Jun 30, 2023 | -394,000.00 |
| Jun 30, 2023 | -394,000.00 |